The PATH Malaria Vaccine Initiative (MVI) is a vaccine development program of PATH. This fact sheet provides an overview of MVI's history, mission, vision, and work.

Publication date: November 2012

Region: Global

This issue of PATH Today leads with the Mama SASHA project, which is improving nutrition, agriculture, and prenatal health care in Kenya. PATH's work to increase access to breast cancer screening in rural Peru is also featured, and donors Bryan and Martha Kim share why contributing to PATH is a smart investment. News briefs include an update about family planning and new work in Myanmar.

Publication date: November 2012

Region: Global

Part of series: PATH Today

This fact sheet summarizes PATH's work to curb emerging and epidemic diseases such as HIV/AIDS, tuberculosis, and malaria. Topic areas include advancing technologies to improve prevention, diagnosis, and treatment; strengthening health systems; encouraging healthy behaviors; and mobilizing and supporting our partners.

Publication date: September 2012

Region: Global

Part of series: Areas of focus fact sheets

This issue of Directions in Global Health features PATH’s Sure Start project, which helped to improve maternal and newborn health in India. Other articles cover strategies to eliminate malaria, advocacy and communications to improve tuberculosis control, a landmark vaccine introduction in Ghana, and a new child-health initiative in southern Africa.

Publication date: May 2012

Region: Global

Part of series: Directions in Global Health

This booklet presents advocacy tips, success stories, and examples of efforts to bridge the worlds of science and policymaking and to help ensure that policymakers at national, regional, and international levels have the information needed to make timely and informed decisions as soon as a first malaria vaccine becomes available for use.

Publication date: February 2012

Region: Africa

This paper describes research into the anticipated processes and data needed to inform decision-making on malaria vaccines, the most advanced of which is still in phase 3 trials.

Author: Brooks A, Ba-Nguz A

Publication date: February 2012

Region: Africa

This fact sheet provides an overview of PATH's work in Zambia, including our work to support data-driven malaria control measures, improve child health and nutrition, prevent HIV infection, and create better information management systems.

Publication date: December 2011

Region: Africa

A malaria vaccine, deployed in combination with current malaria-control tools, could play an important role in the future control and eventual elimination of malaria in Africa. This article, published in the New England Journal of Medicine, reports the initial results of an ongoing phase 3 trial of RTS,S/AS01 being conducted at 11 centers in seven African countries.

Publication date: November 2011

Region: Africa

This report in the Roll Back Malaria Progress & Impact Series details previous malaria elimination and eradication efforts to date and summarizes ongoing progress in all malaria-endemic areas of the world.

Author: Rietveld A, Kurdova-Mintcheva R

Publication date: October 2011

Region: Global

Part of series: Roll Back Malaria Progress & Impact Series

Rapid reporting systems help countries identify and respond to infections in real time. This fact sheet provides an overview of rapid reporting and how it is being used in the field to record and convey information quickly, aiding malaria-elimination efforts.

Publication date: October 2011

Region: Africa

Part of the Roll Back Malaria Progress & Impact Series, this report demonstrates the dramatic successes achieved by the malaria community over the past ten years. As a result of greater commitment and increased resources being made available to national malaria control programs, interventions have reached vulnerable populations and thousands of lives have been saved. The report details the evolution and effectiveness of the Roll Back Malaria Partnership over the years, demonstrating how a strong, well-organized community can help deliver broad health benefits while relieving overburdened health systems.

Author: White Johansson EW, Newby H, Carvajal L, et al

Publication date: September 2011

Region: Global

Part of series: Roll Back Malaria Progress & Impact Series

Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author: Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Publication date: June 2011

Region: Africa

This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade and was followed in 2013 by From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade.

Publication date: June 2011

Region: Global

This report in the Roll Back Malaria Progress & Impact Series examines how private-sector investment in malaria control has improved cost-effectiveness at companies operating in malaria-endemic regions in Africa.

Author: Mouzin E, Sedlmayr R, Miller J, et al

Publication date: May 2011

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

Malaria is a leading cause of morbidity and mortality in children younger than five years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria Journal, explores sociocultural and health communications issues among individuals who are responsible for or influence decisions on childhood vaccination at the community level.

Author: Ojakaa DI, Ofware P, Machira YW, et al

Publication date: May 2011

Region: Africa

This report, part of the Roll Back Malaria Progress & Impact Series, shows how Zambia has built up a strong disease-control program, with well-defined goals and organizational plans.

Author: Mouzin E, Mukonka V, Kamuliwo M, et al

Publication date: April 2011

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

This fact sheet provides an overview of the impact that global and national investment have had in the fight against malaria, with an emphasis on the importance of US support for the President’s Malaria Initiative and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Publication date: February 2011

Region: Africa

This report provides an overview of Nicaragua's health system and diagnostic needs. It is supported by individual case studies on Chagas disease, dengue, and malaria in Nicaragua. These studies focus on several factors influencing the health care system in Nicaragua, including recent trends, regional and national control strategies, financing and partnerships, and the unmet clinical needs associated with each illness.

Author: Sequeira M, Espinoza H, Amador JJ, Domingo G, Quintanilla M, de los Santos T

Publication date: February 2011

Region: Latin America

This fact sheet describes PATH's work to improve malaria diagnosis, treatment, and referral practices in the private sector to contain drug-resistant parasites in Cambodia.

Publication date: January 2011

Region: Asia

The first country report in the Roll Back Malaria Progress & Impact Series, published in collaboration with Senegal’s National Malaria Control Programme, describes how Senegal achieved a spectacular drop in its malaria burden in just five years.

Author: Mouzin E, Thior PM, Diouf MB, Sambou B

Publication date: November 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series